Lignans and tamoxifen, alone or in combination, reduce human breast cancer cell adhesion, invasion and migration in vitro

Breast Cancer Research and Treatment

Volumn 80, Issue 2, 2003, Pages 163-170

  Chen, Jianmin ^a   Thompson, Lilian U ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Breast cancer; Cell invasion; Flaxseed; Lignans; MDA MB 231; MDA MB 435; Metastasis; Tamoxifen

Indexed keywords

COLLAGEN TYPE 4; ENTERODIOL; ENTEROLACTONE; ESTROGEN RECEPTOR; FIBRONECTIN; LAMININ; LIGNAN; MATRIGEL; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CELL INVASION; CONTROLLED STUDY; DOSE RESPONSE; DRUG CROSS REACTIVITY; DRUG EFFECT; DRUG METABOLISM; DRUG POTENTIATION; DRUG RECEPTOR BINDING; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; LINSEED; METASTASIS INHIBITION; NUDE MOUSE; PHYTOTHERAPY; PRIORITY JOURNAL; RECEPTOR DENSITY;

4-BUTYROLACTONE; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; HUMANS; LIGNANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PHYTOTHERAPY; RECEPTORS, ESTROGEN; TAMOXIFEN;

EID: 0038336609     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024513815374     Document Type: Article

References (42)

1. Henderson IC, Patek AJ: The relationship between prognostic and predictive factors in the management of breast cancer. Breast Cancer Res Treat 52: 261-288, 1998
2. Thompson LU: Flaxseed, lignans, and cancer. In: Thompson LU, Cunnane SC (eds) Flaxseed in Human Nutrition. 2nd edn, AOCS Press, Champaign, 2003 (in press)
3. Thompson LU: Experimental studies on lignans and cancer. Baillieres Clin Endocrinol Metab 12: 691-705, 1998
4. Chen JM, Stavro PM, Thompson LU: Dietary flaxseed inhibits breast cancer growth and metastasis and downregulates expression of epidermal growth factor receptor and insulin-like growth factor. Nutr Cancer 43: 187-192, 2002
5. Dabrosin C, Chen J, Wang L, Thompson LU: Flaxseed inhibits metastasis and decreases extracellular vascular endothelial growth factor in human breast cancer xenografts. Cancer Lett 185: 31-37, 2002
6. Yan L, Yee JA, Li D, McGuire MH, Thompson LU: Dietary flaxseed supplementation and experimental metastasis of melanoma cells in mice. Cancer Lett 124: 181-186, 1998
7. Li D, Yee JA, Thompson LU, Yan L: Dietary supplementation with secoisolariciresinol diglycoside (SDG) reduces experimental metastasis of melanoma cells in mice. Cancer Lett 142: 91-96, 1999
8. Forbes JF: The control of breast cancer: the role of tamoxifen. Semin Oncol 24: S1-5-S1-19, 1997
9. Bliss RD, Kirby JA, Browell DA, Lennard TWJ: Inhibition of endothelial adhesion and invasion by breast carcinoma cells may contribute towards the anti-metastatic effects of tamoxifen. Eur J Surg Oncol 22: 27-33, 1996
10. Hoelting T, Duh QY, Clark OH, Herfarth C: Tamoxifen antagonizes proliferation and invasion of estrogenic receptor-negative metastatic follicular thyroid cells via protein kinase C. Cancer Lett 100: 89-93, 1996
11. Mathew AC, Rajah TT, Hurt GM, Abidi SMA, Dmtryk JJ, Pento JT: Influence of antiestrogens on the migration of breast cancer cells using an in vitro wound model. Clin Exp Metastasis 15: 393-399, 1997
12. Gundimeda U, Chen Z-H, Gopalakrishna R: Tamoxifen modulates protein kinase C via oxidative stress in estrogen receptor-negative breast cancer cells. J Biol Chem 271: 13504-13524, 1996
13. Welshons WV, Murphy CS, Koch R, Calaf G, Jordan VC: Stimulation of breast cancer cells in vitro by the environmental estrogen enterolactone and the phytoestrogen equol. Breast Cancer Res Treat 10: 169-175, 1987
14. Zhang RD, Fidler IJ, Price JE: Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metastasis. Invasion Metastasis 11: 204-215, 1991
15. Jiang WG: In vitro models of cancer invasion and metastasis: recent developments. Eur J Surg Oncol 20: 493-499, 1994
16. Frandsen TL, Boysen BE, Jirus S, Zwiebel J, Spang-Thomsen M, Thompson EW, Brunner N: Assays for the study of human cancer cell invasion and metastasis. Fibrinolysis 6(Suppl 4): 71-76, 1992
17. Wang AZ, Chen JM, Fisher GW, Wang JC, Diamond HS: Improved in vitro models for assay of rheumatoid synoviocyte chemotaxis. Clin Exp Rheumatol 12: 293-299, 1994
18. Connolly JM, Rose DP: Effects of fatty acids on invasion through reconstituted basement membrane ('Matrigel') by a human breast cancer cell line. Cancer Lett 75: 137-142, 1993
19. Thompson LU, Rickard SE, Orcheson LJ, Seidl MM: Flaxseed and its lignan and oil components reduce mammary tumor growth at a late stage of carcinogenesis. Carcinogenesis 17: 1373-1376, 1996
20. Rickard SE, Yuan YV, Chen J, Thompson LU: Dose effects of flaxseed and its lignan on N-methyl-N-nitrosourea-induced mammary tumorigenesis in rats. Nutr Cancer 35: 50-57, 1999
21. Pignatelli M, Stamp G: Integrins in tumour development and spread. Cancer Surv 24: 113-127, 1995
22. Liotta LA, Trygvason K, Garbisa S, Hart I, Foltz CM, Shafie S: Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284: 67-68, 1980
23. Rickard SE, Yuan YV, Thompson LU: Plasma insulin-like growth factor I levels in rats are reduced by dietary supplementation of flaxseed or its lignan secoisolariciresinol diglycoside. Cancer Lett 161: 47-55, 2000
24. Kim H, Muller WJ: The role of the epidermal growth factor receptor family in mammary tumorigenesis and metastasis. Exp Cell Res 253: 78-87, 1999
25. Yee D: The insulin-like growth factor system as a treatment target in breast cancer. Semin Oncol 29(3) (Suppl 11): 86-95, 2002
26. Alessandro R, Kohn EC: Signal transduction targets in invasion. Clin Exp Metastasis 19: 265-273, 2002
27. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y: Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262: 5592-5595, 1987
28. Shao ZM, Wu J, Shen ZZ, Barsky SH: Genistein exerts multiple suppressive effects on human breast carcinoma cells. Cancer Res 58: 4851-4857, 1998
29. Shao ZM, Wu J, Shen ZZ, Barsky SH: Genistein inhibits both constitutive and EGF-stimulated invasion in ER-negative human breast carcinoma cell lines. Anticancer Res 18: 1435-1439, 1998
30. Dunn SE, Ehrlich M, Sharp NJ, Reiss K, Solomon G, Hawkins R, Baserga R, Barrett JC: A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer. Cancer Res 58: 3353-3361, 1998
31. Shen F, Xue X, Weber G: Tamoxifen and genistein synergistically down-regulate signal transduction and proliferation in estrogen receptor-negative human breast carcinoma MDA-MB-435 cells. Anticancer Res 59: 1657-1662, 1999
32. O'Brian CA, Liskamp RM, Solomon DH, Weinstein IB: Inhibition of protein kinase C by tamoxifen. Cancer Res 45: 2462-2465, 1985
33. Su HD, Mazzei GJ, Vogler WR, Kuo JF: Effect of tamoxifen, a nonsteroidal antiestrogen, on phospholipid/calcium-dependent protein kinase and phosphorylation of its endogenous substrate proteins from the rat brain and ovary. Biochem Pharmacol 34: 3649-3653, 1985
34. Gelmann EP: Tamoxifen treatment of malignancies other than breast and endometrial carcinoma. Semin Oncol 24(1) (Suppl 1): S1-65-S1-70, 1997
35. Plamontier R, Roberts JD, Glasgow WC, Elling T, Olden K: Regulation of the adhesion of a human carcinoma cell line to type IV collagen and vitronectin: roles for lipoxygenase and protein kinase C. Cancer Res 56: 2206-2212, 1996
36. Yao J, Xiong S, Klos K, Nguyen N, Grijalva R, Li P, Yu D: Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1 in human breast cancer cells. Oncogene 20: 8066-8074, 2001
37. Tanos V, Brzezinski A, Drize O, Strauss N, Peretz T: Synergistic inhibitory effects of genistein and tamoxifen on human dysplastic and malignant epithelial breast cells in vitro. Eur J Obstet Gynecol Reprod Biol 102: 188-194, 2002
38. Furr BJ, Jordan VC: The pharmacology and clinical uses of tamoxifen. Pharmacol Ther 25: 127-205, 1984
39. Morton MS, Wilcox G, Wahlqvist ML, Griffiths K: Determination of lignans and isoflavonoids in human female plasma following dietary supplementation. J Endocrinol 142: 251-259, 1994
40. Bashey A, Corringham S, Garrett J, Lane TA, Gilpin EA, Corringham RE, Law P, Ho AD: A phase II study of two cycles of high-dose chemotherapy with autologous stem cell support in patients with metastatic breast cancer who meet eligibility criteria for a single cycle. Bone Marrow Transplant 25: 519-524, 2000
41. McClay EF, McClay MT, Monroe L, Jones JA, Winski PJ: A phase II study of high dose tamoxifen and weekly cisplatin in patients with metastatic melanoma. Melanoma Res 11: 309-313, 2001
42. Bergan RC, Reed E, Myers CE, Headlee D, Brawley O, Cho HK, Figg WD, Tompkins A, Linehan WM, Kohler D, Steinberg SM, Blagosklonny MV: A phase II study of high-dose tamoxifen in patients with hormone-refractory prostate cancer. Clin Cancer Res 5: 2366-2373, 1999